Insider · CIK 0001831558

Forster Eliot

Reports to the SEC for 3 companies · CARMIEL

sec.gov

Transactions

Companies

Filings

CIK

0001831558

Forms 4 and 5

Insider transactions

21 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-03	PLXProtalix BioTherapeutics, Inc. · Restricted Stock UnitsA Award	Director	AAward	+8,500 sh	—	—	8,500
2026-09-03	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+17K sh	—	—	17,000
2026-06-16	IMTXImmatics N.V. · Stock Option (Right to Buy)A Award	Director	AAward	+48K sh	—	—	48,000
2025-09-03	PLXProtalix BioTherapeutics, Inc.A Award	Director	AAward	+7,500 sh	—	—	7,500
2025-09-03	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2023-09-14	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+85.7K sh	—	—	85,715
2023-03-08	F-star Therapeutics, Inc.D Disposition to Issuer	Director, PRESIDENT AND CEO	DDisposition to Issuer	−74K sh	$7.12	−$527K	0
2023-03-08	F-star Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, PRESIDENT AND CEO	DDisposition to Issuer	−127K sh	—	—	0
2023-03-08	F-star Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, PRESIDENT AND CEO	DDisposition to Issuer	−165K sh	—	—	0
2023-03-08	F-star Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, PRESIDENT AND CEO	DDisposition to Issuer	−128K sh	—	—	0
2023-03-08	F-star Therapeutics, Inc.U Disposition from Tender	Director, PRESIDENT AND CEO	UDisposition from Tender	−348K sh	$7.12	−$2.47M	73,959
2022-07-29	F-star Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	−32.6K sh	—	—	0
2022-07-29	F-star Therapeutics, Inc.M Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	+261K sh	$0.11	+$28.7K	421,537
2022-07-29	F-star Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	−228K sh	—	—	0
2022-03-31	F-star Therapeutics, Inc.Stock Option (right to buy)A Award	Director, PRESIDENT AND CEO	AAward	+127K sh	—	—	126,909
2022-01-09	F-star Therapeutics, Inc.Stock Option (right to buy)A Award	Director, PRESIDENT AND CEO	AAward	+165K sh	—	—	165,028
2021-03-09	F-star Therapeutics, Inc.Stock Option (right to buy)A Award	Director, PRESIDENT AND CEO	AAward	+128K sh	—	—	388,901
2021-02-01	F-star Therapeutics, Inc.A Award	Director, PRESIDENT AND CEO	AAward	+142K sh	—	—	160,560
2020-11-20	F-star Therapeutics, Inc.Stock Option (right to buy)A Award	Director, PRESIDENT AND CEO	AAward	+228K sh	—	—	228,375
2020-11-20	F-star Therapeutics, Inc.Stock Option (right to buy)A Award	Director, PRESIDENT AND CEO	AAward	+32.6K sh	—	—	32,602
2020-11-20	F-star Therapeutics, Inc.A Award	Director, PRESIDENT AND CEO	AAward	+18.6K sh	—	—	18,560

Recent filings

Accepted (ET)
Sep 44
Forster Eliot0001831558-26-000003
SEC(opens sec.gov)
Jun 184
Forster Eliot0000950103-26-009241
SEC(opens sec.gov)
Sep 44
Forster Eliot0001415889-25-023708
SEC(opens sec.gov)
Sep 154
Forster Eliot0001104659-23-101237
SEC(opens sec.gov)
Mar 94
Forster Eliot0000899243-23-007669
SEC(opens sec.gov)
Aug 24
Forster Eliot0001209191-22-044007
SEC(opens sec.gov)
Apr 44
Forster Eliot0001209191-22-022313
SEC(opens sec.gov)
Jan 114
Forster Eliot0001209191-22-002918
SEC(opens sec.gov)
Mar 114
Forster Eliot0001209191-21-019780
SEC(opens sec.gov)
Feb 24
Forster Eliot0001209191-21-006781
SEC(opens sec.gov)
Nov 244
Forster Eliot0001209191-20-060358
SEC(opens sec.gov)

Companies

Address

C/O PROTALIX BIOTHERAPEUTICS, INC. 2 SNUNIT STREET, SCIENCE PARK, POB 455

CARMIEL, 2161401